RxSight RXST
NASDAQ RXST
$6.25 +0.16 (+2.63%)
At close: Aug 21, 2026 · 4:00 PM EDT

RxSight (RXST) Gains from Investment Securities (2020 - 2021)

RxSight's (RXST) quarterly Gains from Investment Securities came in at $5.4 million in Q4 2021, up 115.49% YoY from $2.5 million in Q4 2020, and up 461.54% on a QoQ basis from -$1.5 million in Q3 2021.

RxSight (RXST) Gains from Investment Securities (2020 - 2021) Analysis & Trends

RxSight (RXST) has 2 years of Gains from Investment Securities data on file, last reported at $5.4 million in Q4 2021.

  • Quarterly Gains from Investment Securities rose 115.49% year-over-year to $5.4 million in Q4 2021, while the trailing twelve-month figure through Dec 2022 was $5.4 million (up 116.79% YoY) and the FY2025 annual result came in at $1.5 million, up 113.74% from the prior year.
  • Gains from Investment Securities grew to $5.4 million in Q4 2021, from -$1.5 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $5.4 million in Q4 2021 to a low of -$39.5 million in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn
10 RxSight 259.94 Mn -144.31 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2021 5.43 Mn
Dec 31, 2021 5.43 Mn
Sep 30, 2021 -1.50 Mn
Sep 30, 2021 -1.50 Mn
Jun 30, 2021 -1.21 Mn
Jun 30, 2021 -1.21 Mn
Dec 31, 2020 -35.08 Mn
Dec 31, 2020 -35.08 Mn
Sep 30, 2020 -39.52 Mn
Sep 30, 2020 -39.52 Mn
Jun 30, 2020 4.18 Mn
Jun 30, 2020 4.18 Mn